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Cost-effectiveness of community health workers in tuberculosis
control in Bangladesh
Md. Akramul Islam,1 Susumu Wakai,2 Nobukatsu Ishikawa,3 A.M.R. Chowdhury,4 & J. Patrick Vaughan5
Objective To compare the cost-effectiveness of the tuberculosis (TB) programme run by the Bangladesh Rural Advancement Committee
(BRAC), which uses community health workers (CHWs), with that of the government TB programme which does not use CHWs.
Methods TB control statistics and cost data for July 1996–June 1997 were collected from both government and BRAC thanas
(subdistricts) in rural Bangladesh. To measure the cost per patient cured, total costs were divided by the total number of patients cured.
Findings In the BRAC and government areas, respectively, a total of 186 and 185 TB patients were identified over one year, with cure
rates among sputum-positive patients of 84% and 82%. However, the cost per patient cured was US$ 64 in the BRAC area compared
to US$ 96 in the government area.
Conclusion The government programme was 50% more expensive for similar outcomes. Although both the BRAC and government TB
control programmes appeared to achieve satisfactory cure rates using DOTS (a five-point strategy), the involvement of CHWs was found
to be more cost-effective in rural Bangladesh. With the same budget, the BRAC programme could cure three TB patients for every two in
the government programme.
Keywords Tuberculosis, Pulmonary/prevention and control; Community health aides/utilization/economics; Health personnel/
utilization; National health programs/organization and administration; Rural health services/manpower; Cost-benefit analysis;
Comparative study; Bangladesh (source: MeSH, NLM).
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Introduction
Tuberculosis (TB) remains a major public health problem in
Bangladesh. This is exemplified by the statistics for 1993, when
the incidence was estimated to be 220 people per 100 000
population (1). To address this issue, the Bangladesh Rural
Advancement Committee (BRAC) first initiated a pilot
community-based TB control project in 1984 in Manikganj
thana (subdistrict), with technical support from the Research
Institute of Tuberculosis in Japan (2, 3). This model is currently
being applied in 60 thanas covering a population of approxi-
mately 14 million (about 12% of the population of Bangladesh).
Since 1993, a national TB programme has been
implemented at the thana level, based on the WHO-
recommended DOTS strategy, with each thana covering a
population of about 250 000 (4). Nongovernmental organiza-
tions (NGOs), including BRAC, are collaborating with the
national TB programme. Both BRAC and national TB
programmes use the same treatment regimens (5), but BRAC
mainly relies on the use of community health workers (CHWs)
to deliver directly observed therapy (DOT) while the
government provides DOT mostly through thana health
complexes. According to national TB programme reports,
recent cure rates of between 71% and 75% have been achieved
(6–8). In contrast, a cure rate higher than the WHO target of
85% has been achieved by BRAC, using CHWs (2, 5).
In the present study, we examined the cost-effectiveness
of using CHWs for TB control, by comparing the costs of
BRAC and government services.
Methods
TB control through government thana health
complexes
The government thana health complexes had 31 beds for
inpatients, and staff positions for nine medical doctors. Below
the thana level, services were also available at union subcentres
and family welfare centres, managed by doctors or paramedics
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(8). Below the union level, there was about one health worker
(health assistant) for every 5000–6000 population, who
provided basic health care to the villagers (9).
Patients suspected of having pulmonary TB submitted
three sputum specimens within two days to the thana health
complexes for laboratory examination, and were diagnosed as
sputum positive if two specimens were positive for acid-fast
bacilli (6). If symptoms persisted, but the sputum was negative
for acid-fast bacilli, patients underwent chest radiography at
the private or government health facilities. However, systema-
tic quality control of laboratory services has not yet been
established at thana health complex level.
An 8-month, short-course treatment regimen was used
for treating sputum-positive patients, who underwent follow-
up sputum examinations at 2–3, 5, and 8months (4). In the first
2–3 months, sputum-positive individuals were given drugs
weekly at the thana health complexes, while sputum-negative
patients were given drugs monthly, after which patients
collected drugs monthly from the thana health complexes.
Government health workers traced defaulters.
TB control through CHWs
Each BRAChealth centre had amedical doctor or amanager and
services were mainly provided by CHWs under the supervision
of paramedics (programme organizers). The CHWs were mostly
illiterate women who each covered about 200 households (2). In
the study area, BRAC had two health centres to provide health
care services to the community. Sputum collection centres were
widely available, to increase access.
Suspected TB patients were given sputum containers for
two samples and asked to bring them to the sputum collection
centre, where a third sputum sample was collected. Sputum
smears were prepared and sent to the thana-level laboratory for
staining and microscopy. If symptoms persisted, but the
sputumwas negative, patients were referred to the thana health
complexes or district hospitals. For quality control, 50% of
positive, 5% of negative, and 5% of follow-up sputum slides
were cross-checked by another laboratory technician every
month (2, 5).
Treatment of all TB patients and follow-up sputum
examinations were carried out according to national TB
programme guidelines (4). CHWs observed new patients
swallow the drugs during the first 2–3 months, while patients
undergoing retreatment were observed for the entire period.
After the initial 2–3 month period, patients collected drugs
once a week from the home of the CHW. BRAC staff
supervised the CHWs and other activities regularly.
Patients receiving treatment were asked to deposit
200 Takas (US$ 4; about four days’ wages), and to sign a bond
to guarantee treatment completion. From the bond, 125 Takas
were given to the CHW and the remaining 75 Takas were
refunded to the patient after completing treatment (2, 5).
Patients unable to pay the deposit received a waiver.
Data collection
The data on TB control (treatment of pulmonary and
extrapulmonary TB in children and adults) and costs were
collected from one BRAC thana and one government thana,
located between 65 and 100 kilometres north of Dhaka, the
capital. Sociodemographically, both areas were similar to each
other and to the majority of other thanas (10).
Cost analysis
Costs of health services and CHWs, together with patient
costs, were calculated for one full year (July 1996–June 1997).
Shared costs, including salary, buildings, furniture, supervision,
transportation, and vehicles, were estimated through observa-
tion and interviews with health staff, including CHWs (11).
Staff at each level and CHWs were asked to list their activities
and identify the proportion of time they worked on each
activity.
In both BRAC and government areas, the costs of all
health workers and administrative staff (including CHWs)
were included in the analysis. However, basic staff training
costs were excluded, since training had already been given in
1994 in both areas and costs were estimated to be similar.
BRAC capital costs (including building costs) were derived
from accounting books and financial reports. As government
capital costs were not available, they were estimated according
to the local market price, using current replacement costs.
Annual values of capital items were estimated from their
expected useful life: 10 years for furniture, 5 years for vehicles
and equipment, and were discounted 5% per annum.
Recurrent costs were derived from accounting books
and financial reports in both areas. The BRAC and govern-
ment overhead costs for TB patients were calculated to be 10%
and 5%, respectively, following staff discussions. An inventory
of drugs and logistics used for the TB programmes was
prepared according to the records, and costs were calculated
from the national TB programme price list.
To determine costs incurred by patients for their
diagnosis and treatment, we interviewed a total of 18 BRAC
and 20 government patients. The patients were selected
purposively from individuals who visited health facilities within
a one-week period either for a consultation, to give sputum
tests, or to collect drugs, and they volunteered to provide
information. From the information we calculated time and
travel costs associated with patient visits to health facilities and
treatment centres (for diagnosis, drug collection, and follow-
up tests for cough). Our estimates also included the cost of
each visit for people accompanying the patients.
Time costs were calculated by using the average daily
wage to value a unit of time, and then multiplying this by the
time taken for different activities associated with TB treatment
(e.g. DOT visit to CHWs; collecting drugs from thana health
complexes). Costs for technical support by the Research
Institute of Tuberculosis were not included in costs for the
BRAC area, as they provided support during the pilot phase
(1984–90). All costs were calculated in Bangladesh currency
(Taka) and converted to United States dollars at the 1996–
97 exchange rate of US$ 1.00 = 42.22 Taka.
Effectiveness
Programme data for July 1996–June 1997 were collected from
the respective BRAC and government offices. Treatment
outcomes were analysed according to the WHO-recom-
mended cohort analysis method (12). Programme effective-
ness was determined from data on the number of patients
who were cured, who completed treatment, who were
successfully treated, or who defaulted, died, failed, and
transferred/referred (as defined by the national TB pro-
gramme) (4, 13). Cure and treatment success were used as the
measure of effectiveness.
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Cost-effectiveness
Cost-effectiveness ratios were calculated by dividing the cost per
activity by each different effectiveness measure for July 1996–
June 1997. The cost per patient cured was calculated by dividing
the number of patients cured into the total health system costs.
Similarly, the cost per patient successfully treated was calculated
by dividing the number of patients successfully treated into the
health system costs. The overall total cost per patient cured was
calculated by dividing the total number of patients cured into the
sum of the health system and patient costs.
Results
Cost analysis
The estimated total annual costs for TB control at thana level in
BRAC and government areas were US$ 7351 and US$ 10 697,
respectively (Table 1). The two main expenditures in both areas
were for salaries and drugs, which together accounted for 77%
and 83% of total expenditures for BRAC and government areas,
respectively. Overall, the BRAC programme accounted for 69%
of total government costs for the national TB programme.
Although drug costs were similar in the BRAC and government
thanas, salary costs in the BRAC programme were only 43% of
those in the national TB programme. Costs for laboratory
logistics and reagents were less in thana health complexes, as
they tested only 2300 sputum smears, compared to 3968 sputum
smears tested in BRAC areas.
A breakdown of estimated costs incurred by a typical
patient and a typical CHW for diagnosis and treatment is
shown in Table 2. On average, the total patient cost was about
US$ 10 in the BRAC areas and US$ 19 in government areas.
Effectiveness
Of the 186 patients identified as having TB in the BRAC area in
one year, over 91% were sputum positive and more than 70%
were male (Table 3). Among the sputum-positive patients,
84%were cured and 10% died. A total of 185 TB patients were
identified for the same period in the government thana. Of
these, over 91%were sputum positive and 80%weremale. For
the sputum-positive patients, over 82% were cured and nearly
12% died. Treatment completion rate in sputum-negative
patients was 62.5% in the BRAC area and 87.5% in the
government area. The overall treatment success rate was
83.3% in the BRAC area and 82.7% in the government area.
Cost-effectiveness
In the BRAC area, each cured patient cost the health system
US$ 52, while successfully treated patients cost the system
US$ 48 each. However, the total overall cost per patient cured
was higher, at US$ 64 (Table 4). In the government area, the
equivalent figures were US$ 77, US$ 70, and US$ 96,
respectively.
Discussion
A recent WHO review estimated that only 32% of the world’s
population had access to DOTS (5), a strategy that requires
health workers (or persons accountable to health services)
watch patients swallow their anti-TB drugs (13). In view of this,
it is germane to ask how DOTS can be made more widely
available. One solution would be to keep patients in hospitals
for long stays, but in developing countries where TB is
epidemic, this would increase the burden both on patients and
Table 1. Estimated annual expenditure for tuberculosis control
programmes, BRACa andgovernment areas, July 1996–June 1997
Item Cost (US$)
BRAC Government
programmes programmes
(with CHWs)b (without CHWs)
Furniture 53 (0.70)c 66 (0.60)
Equipment 95 (1.30) 335 (3.10)
Vehicle 2 (0.02) 24 (0.20)
Building 96 (1.30) 253 (2.40)
Salary 2839 (38.60) 6443 (60.20)
Transport 522 (7.10) 108 (1.00)
Staff developmentd 30 (0.40) 101 (1.00)
Training costs for one CHW 96 (1.30) 0 (0.00)
Laboratory logistics 378 (5.20) 277 (2.60)
Reagentse 190 (2.58) 128 (1.20)
Drugse 2787 (37.90) 2580 (24.10)
Overhead costs 263 (3.60) 382 (3.60)
Total expenditures 7351 (100.00) 10 697 (100.00)
a BRAC = Bangladesh Rural Advancement Committee.
b CHWs = community health workers.
c Figures in parentheses are percentages. Percentages for each expenditure
were calculated from the corresponding total expenditure for BRAC and
government programmes.
d Expenses associated with meeting and retraining staff.
e Supplied by the Government of Bangladesh.
Table 2. Costs for tuberculosis control in BRACa and
government areas
Item Cost (US$)
BRAC Government
programmes programmes
(with CHWs)b (without CHWs)
Diagnosis
Loss of income 0.7 (53.8)c 1.4 (23.3)
Transportation costs 0.5 (38.5) 2.2 (36.7)
Examination fees 0.1 (7.7) 2.4 (40.0)
Total 1.3 (100.0) 6.0 (100.0)
Intensive phase treatment
Loss of income 2.8 (100.0) 2.7 (44.3)
Transportation costs 0.0 (0.0) 3.4 (55.7)
Total 2.8 (100.0) 6.1 (100.0)
Continuation phase treatment
Loss of income 1.4 (100.0) 2.1 (42.0)
Transportation costs 0.0 (0.0) 2.9 (58.0)
Total 1.4 (100.0) 5.0 (100.0)
Sputum monitoring
Loss of income 0.9 (52.9) 0.8 (42.1)
Transportation costs 0.8 (47.1) 1.1 (57.9)
Total 1.7 (100.0) 1.9 (100.0)
Bond money 3.0 – 0.0 –
Patient and CHW costs
Total patient costs 10.2 (84.0) 19.0 (100.0)
Cost of time given by a CHW
for TB control
2.0 (16.0) NAd –
Total costs (patient and CHW)
per patient
12.2 (100) 19.0 (100)
a See footnote a, Table 1.
b See footnote b, Table 1.
c Figures in parentheses are percentages. Percentages for each expenditure
were calculated from the corresponding total expenditure for BRAC and
government programmes.
d NA = not applicable.
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hospitals (14–16). Also, the number of hospital beds would be
inadequate to admit all TB patients (2, 17).
There are also problems in promoting DOT for
outpatient clinics, since health services may not be accessible,
particularly in many rural areas in developing countries (18), as
in Bangladesh, where patients collect drugs from government
thana health complexes once a week instead of daily for
observation. Moreover, TB cure rates in some south-east Asia
countries were 76% in Bangladesh, 83% in India, 74% in
Myanmar, 85% in Nepal, and 49% in Indonesia (13).
To ensure universal coverage by DOT, BRAC devel-
oped a model for providing care for TB patients at the
community level that was based on community participation.
Although the BRAC TB control initiative has consistently
achieved the WHO target of an 85% cure rate (2, 5, 19), the
treatment completion rate of sputum-negative and extrapul-
monary patients in BRAC areas was lower than in thana health
complexes. This may be because smear-negative and extra-
pulmonary patients are not a priority in the BRAC programme.
How cost-effective is the BRAC approach using CHWs,
compared to government health services? Although there were
Table 3. Characteristics and outcomes of tuberculosis
(TB) control programmes in BRACa and government areas,
July 1996–June 1997
Characteristics BRAC Government
and outcomes programmes programmes
(with CHWs)b (without CHWs)
TB patients registered (n)
Sputum positive (new cases) 148 (79.6)c 167 (90.3)
Sputum positive (retreatment) 22 (11.8) 2 (1.1)
Sputum negative 13 (7.0) 5 (2.7)
Extrapulmonary 3 (1.6)c 11 (5.9)
Total patients registered 186 (100.)0 185 (100.0)
Patient characteristics
Mean age (years+ 1 SDd) 40.3+15.4 37.7+14.2
Age range (years) 9–75 9–80
Median age (years) 37 36.4
Male (n) 133 (71.5) 148 (80)
Female (n) 53 (28.5) 37 (20)
Treatment results for sputum-positive patients (n)
Cured 143 (84.1) 139 (82.2)
Completed 2 (1.2) 0 (0.0)
Died 17 (10.0) 20 (11.8)
Failure 3 (1.8) 0 (0.0)
Defaulted 4 (2.3) 4 (2.4)
Transferred/referred 1 (0.6 6 (3.6)
Treatment results for sputum-negative
and extrapulmonary patients (n)
Completed 10 62.5 14 (87.5)
Died 3 18.7 0 (0.0)
Defaulted 3 18.7 0 (0.0)
Referred 0 0.0 2 (12.5)
a See footnote a, Table 1.
b See footnote b, Table 1.
c Figures in parentheses are percentages. Percentages for each characteristic and
outcome were calculated from the corresponding total (patient and outcome)
for BRAC and government programmes.
d SD = standard deviation.
Table 4. Cost-effectiveness of community health workers
(CHWs) in tuberculosis control (July 1996–June 1997)
Expenditure Cost (US$)
BRACa Government
programmes programmes
(with CHWs) (without CHWs)
Health system costs
Per patient cured 52.0 – 77.0 –
Per patient successfully treatedb 48.0 – 70.0 –
Total 52.0 (81.0)c 77.0 (80.2)
Patient costs
Per patient loss of income 5.8 – 7.1 –
Per patient monetary loss 4.4 – 11.9 –
Total 10.2 (15.9) 19.0 (19.8)
CHW costs 2.0 (3.1) NAd –
Total costs 64.2 (100.0) 96.0 (100.0)
a See footnote a, Table 1.
b Patients who were cured and completed treatment.
c Figures in parentheses are percentages. Percentages are based on total costs
for the respective programmes.
d NA = not applicable.
Table 5. Characteristics and information for tuberculosis (TB)
control programmes in BRACa and government areas
(July 1996–June 1997)
Characteristics BRAC Government
and information programmes programmes
(with CHWs)b (without CHWs)
Characteristics
Population (n) 336 707 320 530
Literacy rate (people aged 7 years
and older and above) (%)
25.2 30.3
Works in agriculture (%) 73.9 73.2
Own agricultural land (%) 61.1 66.9
Information on tuberculosis control
Total no. health staff involved
in TB control
40 95
No. of field- level health workers 27 52
Total no. of CHWs 184 0
Loss of time per visit for DOT
from CHWs
18.6 min NA
Loss of time per visit for collecting
drugs for SATc from thana health
complexes
NAd 2.69 h
Loss of time per visit for collecting
drugs during continuation phase
from CHWs/thana health
complexes
9.4 min 2.87 h
Loss of time per visit to BRAC
office/thana health complexes
for diagnosis
1.85 h 2.9 h
Transportation cost per visit
to BRAC office/thana health
complexes for diagnosis and
drug collectione
Taka 10.8
(US$ 0.26)b
Taka 24.2
(US$ 0.57)
Cost per smear teste Taka 6.1
(US$ 0.14)
Taka 7.4
(US$ 0.17)
a See footnote a, Table 1.
b See footnote b, Table 1.
c SAT = self-administered treatment during intensive phase.
d NA = not applicable.
e For comparison, the average daily wage (8 h day) = Taka 50.0 (US$ 1.19).
US$ 1= Taka 42.22 in 1996–97.
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similar cure rates in both the BRAC and government areas, total
health system costs in BRAC areas were substantially lower
(48%) than in government facilities. Also, salary costs weremuch
higher in the government areas, where more field staff were
employed (Table 5), as were the costs incurred by patients.
In the BRAC area, the CHW lived in the same village as
the patients and thus patient costs were much less, despite the
fact that patients visited CHWs daily under the BRAC TB
control strategy. In the government programme, by contrast,
visits for drug collection were fewer, but patient costs were
much higher due to the greater distances they had to travel. In
addition, nearly one-half of government patients were advised
to undergo further tests, including chest X-rays at private
facilities. Under the BRAC programme, the additional tests
were not required if the patients were sputum positive, in line
with the national guidelines (4). Thus, local services in the
community can reduce patient costs considerably (16).
However, both the BRAC and government costs recorded in
this study were lower than those in other, similar settings
(20, 21). Population density, health services infrastructure,
drug prices, and the general economic conditions of the
country are important determinants of such costs.
Another important feature of the BRAC programme is
that it identified more female patients, probably because
women patients are more likely to approach a female CHW
than a male CHW.
Our study showed that when CHWs are used, the DOT
strategy was less expensive and more cost-effective than the
government health services in a resource-poor country like
Bangladesh. Data from a study in South Africa pointed to a
similar conclusion (20). However, in the BRAC programme,
the costs for diagnosis may be greater, due to the higher
number of suspected patients referred by CHWs for sputum
tests. This is partly due to the fact that patients in BRAC areas
have easier access to CHWs and can be treated at their homes.
Such patients can also continue their family and economic
activities (5, 20).
In conclusion, the government programme appeared to
be 50% more expensive than the equivalent government
programme, for similar outcomes. For the same money,
therefore, the BRAC programme could diagnose, treat, and
cure three TB patients, while only two patients would be cured
under the government programme. In Bangladesh, where most
CHW programmes are run by NGOs, we recommend that the
government health services collaborate with NGOs to mobilize
CHWs for TB control. Such programmes could be more cost-
effective and for the same funds could treat about 50%more TB
patients than the regular national programme. n
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Re´sume´
Rapport couˆt-efficacite´ du recours a` des agents de sante´ communautaires dans la lutte contre la tuberculose
au Bangladesh
Objectif Comparer le rapport couˆt-efficacite´ du programme de
lutte antituberculeuse conduit par le Bangladesh Rural Advance-
ment Committee (BRAC) – qui fait appel a` des agents de sante´
communautaires – a` celui du programme gouvernemental de lutte
antituberculeuse – qui n’utilise pas ce type de personnel.
Me´thodes Les statistiques de la lutte antituberculeuse et les
donne´es sur les couˆts pour la pe´riode juillet 1996-juin 1997 ont e´te´
rassemble´es pour les sous-districts desservis par le programme
gouvernemental et le programme du BRAC dans des zones rurales
du Bangladesh. Pour mesurer le couˆt par patient gue´ri, on a divise´
le couˆt total par le nombre total de patients gue´ris.
Re´sultats Dans les zones desservies par le programme du BRAC
et par le programme gouvernemental, on a identifie´ sur un an,
respectivement, 186 et 185 patients atteints de tuberculose, avec
des taux de gue´rison de 84 % et 82 % chez les sujets a` frottis
positif. Le couˆt par patient gue´ri e´tait cependant de US$ 64 dans la
zone desservie par le BRAC contre US$ 96 dans la zone du
programme gouvernemental.
Conclusion Pour un re´sultat identique, le programme gouverne-
mental couˆtait 50 % de plus. Bien que les deux programmes aient
obtenu des taux de gue´rison satisfaisants en appliquant une
strate´gie en cinq points appele´e DOTS, la participation d’agents de
sante´ communautaires s’est ave´re´e d’un meilleur rapport couˆt-
efficacite´ dans les zones rurales du Bangladesh. A budget e´gal, le
programme du BRAC pourrait gue´rir trois malades contre deux
avec le programme gouvernemental.
Resumen
Costoeficacia de los agentes de salud comunitarios en la lucha contra la tuberculosis en Bangladesh
Objetivo Comparar la costoeficacia del programa contra la
tuberculosis dirigido por el Comite´ para el Progreso Rural de
Bangladesh (BRAC), en el que se recurre a agentes de salud
comunitarios, con la del programa gubernamental contra la
tuberculosis, que no hace uso de tales agentes.
Me´todos A partir de material de la Administracio´n y de las thanas
(subdistritos) del BRAC en el Bangladesh rural, se recopilaron
estadı´sticas sobre la lucha antituberculosa y datos sobre los costos
correspondientes para el periodo de julio de 1996 a junio de 1997.
El costo por paciente curado se determino´ dividiendo los costos
totales por el nu´mero de pacientes que sanaron.
Resultados En las zonas abarcadas por el BRAC y por el Gobierno
se identificaron en total 186 y 185 enfermos de tuberculosis,
respectivamente, a lo largo de un an˜o, con tasas de curacio´n del
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84% y el 82% entre los pacientes con esputo positivo. Sin
embargo, el costo por paciente curado fue de US$ 64 en las zonas
del BRAC, y de US$ 96 en la zona de la Administracio´n.
Conclusio´n El programa gubernamental era un 50% ma´s
costoso a igualdad de resultados. Aunque tanto dicho programa
como el programa gubernamental lograron tasas de curacio´n
satisfactorias mediante la estrategia DOTS de 5 puntos, la
participacio´n de los agentes de salud comunitarios resulto´ ser
una opcio´n ma´s costoeficaz en las zonas rurales de Bangladesh.
Con el mismo presupuesto, el programa del BRAC podı´a curar a
tres enfermos de tuberculosis por cada dos curados en el
programa gubernamental.
References
1. Kumaresan JA, Raviglione MC, Murray CJL. Tuberculosis. In: Murray CJL, Lopez
AD, editors. Global health statistics — global burden of disease and injury
series. Vol 2. Boston (MA): Harvard University Press; 1996. p. 142-7.
2. Chowdhury AMR, Chowdhury S, Islam MN, Islam A, Vaughan JP. Control
of tuberculosis by community health workers in Bangladesh. Lancet 1997;
350:169-72.
3. Chowdhury AMR, Ishikawa N, Alam A, Islam MS, Hossain S, Cash RA, et al.
Controlling a forgotten disease: using voluntary health workers for tuberculosis
control in rural Bangladesh. IUATLD Newsletter 1991;December:2-5.
4. National guidelines for tuberculosis control, 2nd edition Dhaka: Ministry of
Health and Family Welfare; 1996.
5. Islam MA, Nakamura Y, Wongkhomthong S, Chowdhury SA, Ishikawa N.
Involvement of community health workers in tuberculosis control in
Bangladesh. Japanese Journal of Tropical Medicine and Hygiene 1999;
27:167-3.
6. Kumaresan JA, Ashan Ali AK, Parkkali LM. Tuberculosis control in Bangladesh:
success of the DOTS strategy. International Journal of Tuberculosis and Lung
Disease 1998;2:992-8.
7. Netto EM, Dye C, Raviglione MC. Progress in global tuberculosis control 1995–
1996, with emphasis on high-incidence countries. International Journal of
Tuberculosis and Lung Disease 1999;3:310-20.
8. Review of the national tuberculosis programme of Bangladesh. Geneva: World
Health Organization; 1998. Unpublished document WHO/TB/98.238.
9. Khan SH, Chowdhury AMR, Karim F, Barua MK. Training and retaining
shasthyo shebika: reasons for turnover of community health workers in
Bangladesh. Health Care Supervision 1998;17:37-47.
10. Statistical Yearbook of Bangladesh. Dhaka: Government of Bangladesh,
Ministry of Planning; 1999.
11. Creese A, Parker D. Cost analysis in primary health care: a training manual for
programme managers. Geneva: World Health Organization; 1994.
12. Treatment of tuberculosis: guidelines for national programmes. Geneva: World
Health Organization; 1997.
13. Global tuberculosis control: WHO report 2001. Geneva: World Health
Organization; 2001.
14. Foster SD. Affordable clinical care for HIV related illness in developing countries.
Tropical Diseases Bulletin 1990;87:1-9.
15. Okot-Nwang M, Wabwire-Mangen F, Kagezi VBA. Increasing prevalence of
tuberculosis among Mulago hospital admissions, Kampala, Uganda (1985–
1989). Tuberculosis and Lung Disease 1993;74:121-5.
16. Saunderson PR. An economic evaluation of alternative programme designs
for tuberculosis control in rural Uganda. Social Science and Medicine
1995;40:1203-12.
17. China Tuberculosis Control Collaboration. Results of directly observed short-
course chemotherapy in 112 842 Chinese patients with smear-positive
tuberculosis. Lancet 1996;347:358-62.
18. Maher D, Hausler HP, Raviglione MC, Kaleeba N, Aisu T, Fourie B, et al.
Tuberculosis care in community care organizations in sub-Saharan Africa:
practice and potential. International Journal of Tuberculosis and Lung Disease
1997;1:276-83.
19. Kochi A. Tuberculosis control — is DOTS the health breakthrough of the
1990s? World Health Forum 1997;18:225-32.
20. Floyd K, Wilkinson D, Gilks C. Comparison of cost effectiveness of directly
observed treatment (DOT) and conventional delivered treatment for
tuberculosis: experience from rural South Africa. BMJ 1997;315:1407-11.
21. Murray CJL, Dejonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. Cost
effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan
African countries. Lancet 1991;338:1305-8.
450 Bulletin of the World Health Organization 2002, 80 (6)
Special Theme – Tuberculosis
